France Thomas D
Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53705, USA.
Am Orthopt J. 2010;60:73-81. doi: 10.3368/aoj.60.1.73.
During the past forty-plus years there have been many advances in our understanding of amblyopia. It has been my privilege to be able to have a close relationship with many of the people that made these contributions. It is the purpose of this paper to trace these changes as they developed from 1965 to the present.
1950s and 1960s: Beginning with the introduction of electrodes that could record from a single cell in the mammalian visual cortex, researchers began to map out the normal physiology of the visual cortex, the lateral geniculate bodies and the retinal ganglion cells. Amblyopia, especially stimulus deprivation amblyopia, became a focus of many of these studies. As more and more information became available, clinicians began to understand the problems that they had been facing in such cases as congenital cataracts, unilateral congenital corneal opacities, etc. This led to a significant change in our approach to such cases with emphasis on earlier and earlier intervention to achieve better visual results. 1970S and 1980S: Scientific studies of patients using techniques such as Contrast Sensitivity Function, Teller Acuity Cards, and Neutral Density filters allowed us to begin to look at development of vision in infants, to characterize the differences between the various types of amblyopia and to better understand the need for amblyopia treatment. At about the same time, interest in vision screening in children allowed us to detect amblyopia at an earlier time of life, which then gave us a better chance of successful treatment. 1990S and the 21ST century: Arenewed interest in developing evidence-based results in keeping with the rest of the scientific medical community led to large multicenter trials looking at different modes of amblyopia treatment with the result of a wider armamentarium available to the practitioner.
While there have been many improvements in our knowledge of the etiology of amblyopia and its treatment, we still find that it is the practitioner, the orthoptist, the patient's family, and the child that make the final difference in success or failure. However, our ability to explain what and why we are doing has made this job easier and given us the tools we need to feel confident in our approach to this still common condition.
在过去四十多年里,我们对弱视的认识有了许多进展。我有幸能与许多做出这些贡献的人建立密切关系。本文旨在追溯从1965年至今这些变化的发展历程。
20世纪50年代和60年代:从能够记录哺乳动物视觉皮层单个细胞活动的电极问世开始,研究人员着手绘制视觉皮层、外侧膝状体和视网膜神经节细胞的正常生理图谱。弱视,尤其是形觉剥夺性弱视,成为了许多此类研究的焦点。随着越来越多的信息被获取,临床医生开始理解他们在处理先天性白内障、单侧先天性角膜混浊等病例时所面临的问题。这导致了我们对此类病例的处理方式发生重大转变,强调越来越早地进行干预以获得更好的视力结果。20世纪70年代和80年代:运用对比敏感度函数、泰勒视力卡片和中性密度滤光片等技术对患者进行科学研究,使我们开始关注婴儿视力的发育,明确不同类型弱视之间的差异,并更好地理解弱视治疗的必要性。大约在同一时期,对儿童视力筛查的关注使我们能够在生命早期检测出弱视,从而为成功治疗提供了更好的机会。20世纪90年代和21世纪:与其他科学医学领域保持一致,对基于证据的研究结果的新兴趣促使开展了大型多中心试验,研究不同的弱视治疗模式,结果是从业者可使用的治疗方法更加多样。
虽然我们对弱视病因及其治疗的认识有了许多改进,但我们仍然发现,最终决定治疗成败的是从业者、视光师、患者家属和儿童。然而,我们解释我们正在做什么以及为什么这样做的能力使这项工作变得更容易,并为我们提供了在处理这种仍然常见的病症时所需的自信工具。